Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director · CEO and President | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 122,423 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Sale · Disposed 10,000 · Balance 122,423 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2023 Filed Feb 27, 2023 21:56 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,473 | $147.86 | $217,797.78 |
DisclosureSEC source: 0001022079-23-000038 · wf-form4_167753497328240.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,315 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 13,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000154 · wf-form4_166750767630564.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,788 F1 · security: Represents an award of restricted share units. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 10,330 | $130.09 | $1,343,829.70 |
DisclosureSEC source: 0001022079-22-000052 · wf-form4_164686177213744.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,808 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 19,856 | $130.09 | $2,583,067.04 |
DisclosureSEC source: 0001022079-22-000052 · wf-form4_164686177213744.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,138 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:48 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 47,529 | $0.00 Strike: $127.73 | $0.00 |
DisclosureSEC source: 0001022079-22-000037 · wf-form4_164609567521992.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,529 Underlying: Common Stock · 47,529 shares Expires 2032-02-24 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:48 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 9,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000037 · wf-form4_164609567521992.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,282 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:03 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 724 | $130.23 | $94,286.52 |
DisclosureSEC source: 0001022079-22-000013 · wf-form4_164583380035294.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,495 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:03 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,712 | $130.09 | $222,714.08 |
DisclosureSEC source: 0001022079-22-000013 · wf-form4_164583380035294.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,219 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 8,334 | $115.42 | $961,910.28 |
DisclosureSEC source: 0001022079-21-000050 · wf-form4_161549775337428.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,931 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 16,570 | $115.42 | $1,912,509.40 |
DisclosureSEC source: 0001022079-21-000050 · wf-form4_161549775337428.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,265 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 806 | $121.19 | $97,679.14 |
DisclosureSEC source: 0001022079-21-000044 · wf-form4_161428928915885.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,695 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,250 | $121.15 | $151,437.50 |
DisclosureSEC source: 0001022079-21-000044 · wf-form4_161428928915885.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,501 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 31,774 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000015 · wf-form4_161378461299805.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,774 Underlying: Common Stock · 31,774 shares Expires 2031-02-17 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000015 · wf-form4_161378461299805.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,751 F1 · security: Represents an award of restricted share units. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 500 | $90.15 | $45,073.00 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 5 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,086 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $89.67 to $90.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 421 | $88.53 | $37,269.03 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 4 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,586 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $88.36 to $88.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,307 | $87.81 | $114,771.59 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,007 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $87.23 to $88.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,085 | $86.65 | $94,019.59 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,314 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $86.19 to $87.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 200 | $85.59 | $17,118.00 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,399 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.19 to $85.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 21:02 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 3,846 | $106.46 | $409,445.16 |
DisclosureSEC source: 0001022079-20-000079 · wf-form4_158404693046672.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,599 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The numbers in this column reflect beneficial ownership as of March 10, 2020, and do not include 19 shares that were inadvertently reported as beneficially owned by the reporting person on the Form 4 filed on February 28, 2020. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 21:02 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 7,359 | $106.46 | $783,439.14 |
DisclosureSEC source: 0001022079-20-000079 · wf-form4_158404693046672.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,445 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 22:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,100 | $109.02 | $119,922.00 |
DisclosureSEC source: 0001022079-20-000059 · wf-form4_158293022576312.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,105 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,187 | $112.90 | $134,012.30 |
DisclosureSEC source: 0001022079-20-000059 · wf-form4_158293022576312.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,205 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 510 | $111.09 | $56,655.90 |
DisclosureSEC source: 0001022079-20-000059 · wf-form4_158293022576312.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,392 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 552 | $113.34 | $62,563.68 |
DisclosureSEC source: 0001022079-20-000048 · wf-form4_158275283053318.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,902 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 598 | $112.73 | $67,412.54 |
DisclosureSEC source: 0001022079-20-000048 · wf-form4_158275283053318.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,454 F2 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 643 | $112.17 | $72,125.31 |
DisclosureSEC source: 0001022079-20-000048 · wf-form4_158275283053318.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,052 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 40,120 | $0.00 Strike: $112.17 | $0.00 |
DisclosureSEC source: 0001022079-20-000030 · wf-form4_158224890205995.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,120 Underlying: Common Stock · 40,120 shares Expires 2030-02-18 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000030 · wf-form4_158224890205995.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,695 F1 · security: Represents an award of restricted share units. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 77,865 | $66.51 Strike: $66.51 | $5,178,801.15 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · derivative · entry 8 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 77,865 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F7 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 65,681 | $71.17 Strike: $71.17 | $4,674,516.77 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · derivative · entry 7 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,681 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F6 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,853 | $106.51 | $942,941.88 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · nonDerivative · entry 6 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,543 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $106.01 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 69,003 | $105.45 | $7,276,504.36 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · nonDerivative · entry 5 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,396 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $105.00 to $106.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 7,423 | $106.51 | $790,646.00 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · nonDerivative · entry 4 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,399 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $106.00 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 58,258 | $105.46 | $6,143,772.16 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,822 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $105.00 to $105.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 77,865 | $66.51 | $5,178,801.15 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 65,681 | $71.17 | $4,674,516.77 |
DisclosureSEC source: 0001022079-20-000002 · wf-form4_157808754276203.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 47,574 | $60.68 Strike: $60.68 | $2,886,552.45 |
DisclosureSEC source: 0001022079-19-000120 · wf-form4_155631055894991.xml · derivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,574 shares Expires 2023-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 7, 2019. F2 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on May 20, 2014, the second on May 20, 2015 and the final on May 20, 2016. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 47,574 | $95.00 | $4,519,530.00 |
DisclosureSEC source: 0001022079-19-000120 · wf-form4_155631055894991.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,534 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 7, 2019. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 47,574 | $60.68 | $2,886,552.45 |
DisclosureSEC source: 0001022079-19-000120 · wf-form4_155631055894991.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 7, 2019. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,100 | $90.70 | $190,476.30 |
DisclosureSEC source: 0001022079-19-000108 · wf-form4_155492822046893.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,534 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 7, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $90.61 to $90.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,900 | $90.15 | $531,855.50 |
DisclosureSEC source: 0001022079-19-000108 · wf-form4_155492822046893.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,634 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 7, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $89.61 to $90.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5,839 | $86.86 | $507,175.54 |
DisclosureSEC source: 0001022079-19-000089 · wf-form4_155182126646581.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,534 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 10,225 | $86.86 | $888,143.50 |
DisclosureSEC source: 0001022079-19-000089 · wf-form4_155182126646581.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,321 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:15 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,432 | $87.84 | $125,786.88 |
DisclosureSEC source: 0001022079-19-000070 · wf-form4_155139211793367.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,096 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:22 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 547 | $88.24 | $48,267.28 |
DisclosureSEC source: 0001022079-19-000054 · wf-form4_155130976041595.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,528 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 00:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 506 | $88.39 | $44,725.34 |
DisclosureSEC source: 0001022079-19-000036 · wf-form4_155114160824854.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,075 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 60,450 | $0.00 Strike: $86.63 | $0.00 |
DisclosureSEC source: 0001022079-19-000020 · wf-form4_155070463311392.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,450 Underlying: Common Stock · 60,450 shares Expires 2029-02-18 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000020 · wf-form4_155070463311392.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,581 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,122 | $101.00 | $517,322.00 |
DisclosureSEC source: 0001022079-18-000088 · wf-form4_152038317924738.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,067 F4 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.